课题基金 / 基金详情

SPORE in Lung Cancer

SPORE in Lung Cancer
肺癌中的孢子
批准号:
7284876
负责人:
BRUCE E. JOHNSON
金额:
$100.21万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-19 至 2008-06-30
关键词:
Angiogenesis PathwayApplications GrantsAreaAwardBiologicalBiostatistics CoreBostonBreastBudgetsCCAAT-Enhancer-Binding Protein-alphaCDK2 geneCEBPA geneCancer CenterCancer PatientCancer cell lineCell CycleClinical TrialsCommunitiesDana-Farber Cancer InstituteDevelopmentDiagnosticDiagnostic ProcedureDiseaseDrug FormulationsEnvironmental Tobacco SmokeEquipmentEvaluationExposure toFinancial SupportFundingGeneral HospitalsGenerationsGenetic Predisposition to DiseaseGenomicsGoalsGrantHealthHospitalsHumanIn VitroIncidenceInternationalInvestigationK-Series Research Career ProgramsLung AdenocarcinomaMalignant neoplasm of lungMalignant neoplasm of prostateMassachusettsModelingMolecularMolecular Classification of TumorsMolecular TargetMusNon-Small-Cell Lung CarcinomaNude MiceNurses&apos Health StudyOutcomeParticipantPathogenesisPathologyPathway interactionsPatientsPersonal SatisfactionPhysiciansPlayPopulationPopulation ControlPopulation SciencesProcessProspective StudiesPublic Health SchoolsResearchResearch InfrastructureResearch PersonnelResourcesRiskRoleSmokingStagingSurrogate EndpointTechniquesTechnologyTestingTimeTissuesTobacco smokeTranslationsTumor Suppressor GenesUniversitiesValidationVascular Endothelial Growth Factor ReceptorVascular Endothelial Growth Factor Receptor-2WagesWomanangiogenesisbasecancer cellcareerchemotherapycohortcostdesigneducation planningexperiencein vivoinhibitor/antagonistleukemiamedical schoolsmennamed groupprogramssmall moleculetherapeutic targettranscription factortranslational studytumor

项目摘要

项目成果

BRUCE E. JOHNSON的其他基金

相关文献

中文摘要
翻译
描述(由申请人提供):本申请在哈佛大学达纳法伯/哈佛癌症中心创建了一个肺癌卓越研究专业计划(SPORE)。 丹娜-法伯/哈佛癌症中心肺癌SPORE包括来自波士顿所有哈佛附属医院、哈佛医学院和哈佛公共卫生学院的研究人员。 肺癌的SPORE将建立在DF/HCC内已建立的正在进行的研究的优势之上。 项目1将评估男性和女性肺腺癌遗传易感性的影响及其与烟草烟雾暴露的相互作用。 项目2将分析肺癌中C/EBP α的失调,其下游靶点及其对肺癌患者预后的潜在影响。 项目3将应用阵列技术研究人类肺癌及其与小鼠模型的关系。 项目4将研究cdk 2抑制剂在体外和体内的作用,并将这些发现应用于肺癌患者的人体试验。 项目4将研究血管内皮生长因子受体抑制剂和化疗在体内的作用,并将这些发现应用于肺癌患者的人体试验。 这些项目通过建立4个核心来整合。 其中包括1)组织和病理学核心,2)管理,评估和规划核心,3)生物统计学核心,4)基因组学核心。 此SPORE应用程序概述了一个发展项目计划,其中包括我们选择新项目的计划,并包括七个提交的建议,可以支持。 职业发展奖励计划概述了识别和支持有才华的年轻肺癌研究人员的机制。 发展项目和职业发展奖励计划将为社区参与DF/HCC肺癌SPORE的规划和财政支持提供重点。 DF/HCC肺癌SPORE的目标是将生物学和技术进步转化为对肺癌患者和有肺癌风险的受试者有临床意义的进步。
英文摘要
DESCRIPTION (provided by applicant): This application creates a Specialized Program in Research Excellence (SPORE) in Lung Cancer at Harvard University within the Dana Farber/Harvard Cancer Center. The Dana-Farber/Harvard Cancer Center SPORE in Lung Cancer includes investigators from all Harvard-affiliated hospitals in Boston, Harvard Medical School, and the Harvard School of Public Health. This SPORE in Lung Cancer will build on the strengths of established ongoing investigation within the DF/HCC. Five major projects are supported: Project 1 will assess the impact of inherited susceptibility to adenocarcinoma of the lung in men and women and its interaction with exposures to tobacco smoke. Project 2 will analyze the dysregulation of C/EBP alpha in lung cancer, its downstream targets, and its potential impact on the outcome of lung cancer patients. Project 3 will apply array technology to the study of human lung cancer and its relationship to murine models. Project 4 will investigate the role of cdk2 inhibitors in vitro, in vivo, and apply these finding to human trials for patients with lung cancer. Project 4 will study the role of vascular endothelial growth factor receptor inhibitors and chemotherapy in vivo, and apply these finding to human trials for patients with lung cancer. These Projects are integrated by the establishment of 4 cores. These include 1) Tissue and Pathology Core, 2) Administration, Assessment and Planning Core, 3) Biostatistics Core, 4) Genomics Core. This SPORE application outlines a Developmental Projects Program that includes our plan for selection of new projects and includes seven submitted proposals that could be supported. The Career Developmental Award Program outlines the mechanism for the identification and support of talented young investigators in lung cancer. The Developmental Projects and Career Development Award Program will provide the focus for involvement of the community in planning and financial support of the DF/HCC Lung Cancer SPORE. The goal of the DF/HCC Lung Cancer SPORE is the translation of biological and technological advances into clinically meaningful advances for patients with lung cancer and subjects at risk for lung cancer.
期刊论文(137)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1158/1078-0432.ccr-08-1455
发表时间: 2008-11-01
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者: [Costa DB, Nguyen KS, Cho BC, Sequist LV, Jackman DM, Riely GJ, Yeap BY, Halmos B, Kim JH, Jänne PA, Huberman MS, Pao W, Tenen DG, Kobayashi S]
通讯作者: Kobayashi S
DOI: 10.1097/jto.0b013e31827db604
发表时间: 2013-03
期刊: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
影响因子: --
作者: [Sholl LM, Weremowicz S, Gray SW, Wong KK, Chirieac LR, Lindeman NI, Hornick JL]
通讯作者: Hornick JL
Outcomes after combined modality therapy for EGFR-mutant and wild-type locally advanced NSCLC.
EGFR突变剂和野生型局部晚期NSCLC的合并方式治疗后的结果。
DOI: 10.1634/theoncologist.2011-0040
发表时间: 2011
期刊: The oncologist
影响因子: --
作者: [Mak RH, Doran E, Muzikansky A, Kang J, Neal JW, Baldini EH, Choi NC, Willers H, Jackman DM, Sequist LV]
通讯作者: Sequist LV
DOI: 10.1158/0008-5472.can-11-0213
发表时间: 2011-10-01
期刊: Cancer research
影响因子: 11.2
作者: [Wang M, Morsbach F, Sander D, Gheorghiu L, Nanda A, Benes C, Kriegs M, Krause M, Dikomey E, Baumann M, Dahm-Daphi J, Settleman J, Willers H]
通讯作者: Willers H
共 92 条
    Biospecimen Unit
    • 批准号:
      10902520
    • 项目类别:
    • 资助金额:
      $124.11万
    • 财政年份:
      2023
    • 负责人:
      BRUCE E. JOHNSON
    • 依托单位:
    The Cellular Geography of Therapeutic Resistance in Cancer
    • 批准号:
      9791162
    • 项目类别:
    • 资助金额:
      $252.48万
    • 财政年份:
      2018
    • 负责人:
      BRUCE E. JOHNSON
    • 依托单位:
    The Cellular Geography of Therapeutic Resistance in Cancer
    • 批准号:
      10259732
    • 项目类别:
    • 资助金额:
      $239.78万
    • 财政年份:
      2018
    • 负责人:
      BRUCE E. JOHNSON
    • 依托单位:
    Biospecimen Unit
    • 批准号:
      10259735
    • 项目类别:
    • 资助金额:
      $57.56万
    • 财政年份:
      2018
    • 负责人:
      BRUCE E. JOHNSON
    • 依托单位: